r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
Comparison · Analytics
pharmaverseadam vs RBesT
A side-by-side editorial comparison of pharmaverseadam and RBesT — release velocity, themes, recent moves, and the top alternatives to consider.
Shared themes:r-language
pharmaverseadam vs RBesT: at a glance
What is pharmaverseadam?
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
What is RBesT?
RBesT is teaching its Bayesian decision rules to answer two-sided questions.
RBesT builds meta-analytic-predictive priors — the machinery for borrowing historical control data into a new trial — and evaluates the operating characteristics of decisions made with them. The stable line has spent several releases on effective sample size: ESS for normal mixtures via a new `family` argument, boundary corrections when no responses or no non-responses are observed, and stabilised ELIR computations. The 1.9-0 release candidate extends the normal, binomial and Poisson outcome functions to two-sided decisions.
pharmaverseadam vs RBesT: editorial side-by-side
pharmaverseadam
0.0ANALYTICS
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
◆ Current state
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
◆ Where it's heading
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
◆ Prediction
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
RBesT
0.0ANALYTICS
RBesT is teaching its Bayesian decision rules to answer two-sided questions.
◆ Current state
RBesT builds meta-analytic-predictive priors — the machinery for borrowing historical control data into a new trial — and evaluates the operating characteristics of decisions made with them. The stable line has spent several releases on effective sample size: ESS for normal mixtures via a new `family` argument, boundary corrections when no responses or no non-responses are observed, and stabilised ELIR computations. The 1.9-0 release candidate extends the normal, binomial and Poisson outcome functions to two-sided decisions.
◆ Where it's heading
Two currents run through the changelog. One is ESS hardening — nearly every release since 1.7-4 fixes another edge case where the ELIR calculation aborted or returned something unstable, which is what happens when a quantity used to justify prior strength to regulators gets scrutinised. The other is Stan and brms integration debt: array syntax updates, a minimum Stan version bump, truncated prior generation for `mixstanvar`, deterministic EM. The RC's contributor list shows a second active maintainer, and the work is broader than any recent stable release.
◆ Prediction
The release candidate covers all three outcome families and has already absorbed a round of review comments, so the next step is most likely the 1.9-0 CRAN release itself rather than further feature work.
Alternatives to pharmaverseadam and RBesT
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaverseadam or RBesT.
DoseFinding
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
webmockr
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul
crul took mocking back from webmockr and made it a property of the client itself
dendroNetwork
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all pharmaverseadam alternatives → · See all RBesT alternatives →
Recent activity from pharmaverseadam and RBesT
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 5mo agoRBesTTwo-sided decisions across normal, binomial and Poisson outcomes ⚡
- 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
- 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
- 1y agoRBesTJSON read and write for mixture objects
- 1y agoRBesTess() fixed inside apply functions
- 1y agoRBesTESS for normal mixtures in the exponential family
- 1y agoRBesTTruncated mixture priors for brms, plus faster Stan models
- 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
- 2y agopharmaverseadam1.0 declares the dataset collection stable
- 2y agoRBesTStan array syntax update and CRAN system requirements
- 2y agopharmaverseadamFirst release of the ADaM dataset collection
Frequently asked questions
What is the difference between pharmaverseadam and RBesT?
Both compete on the same themes — r-language — within Analytics. pharmaverseadam and RBesT are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is pharmaverseadam better than RBesT?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. pharmaverseadam and RBesT are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to pharmaverseadam?
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.
What are the best alternatives to RBesT?
Top RBesT alternatives in Analytics are ranked by recent ship velocity. Browse the "RBesT alternatives" section above for the current picks, or visit /alternatives/rbest for the full list with editorial commentary on each.